March 30 (Reuters) - Sedana Medical AB (publ) SEDANA.ST :
* SEDANA MEDICAL SEES INCREASED DEMAND AND KEEPS TIME
SCHEDULE
* COMPANY SEES INCREASED DEMAND FOR ANACONDA AS A RESULT OF
COVID-19 PANDEMIC AND SO FAR, HAS HAD NO SIGNIFICANT SUPPLY
CHAIN DISRUPTIONS
* FORECASTS A SALES INCREASE OF ABOUT 50 PERCENT FOR Q1 OF
2020
AND ABOUT 100 PERCENT FOR MONTH OF MARCH, COMPARED TO SAME
PERIODS LAST YEAR
* DUE TO COVID-19 PANDEMIC SEDANA MEDICAL SEES A SLIGHT RISK
OF
DELAY OF COMPILATION OF ISOCONDA STUDY UNTIL BEGINNING OF Q3 OF
2020
* STILL EXPECTS TO KEEP TIMETABLE AND SUBMIT APPLICATION IN
Q3, OR
EARLY IN Q4 OF 2020 AND AN APPROVAL DURING SECOND HALF OF 2021
Source text for Eikon: ID:nWkr1x7BkK
Further company coverage: SEDANA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))